BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 3891014)

  • 21. Saturable [D-Ala2, D-Leu5]-enkephalin transport into cholinergic synaptic vesicles.
    Day NC; Wien D; Michaelson DM
    FEBS Lett; 1985 Apr; 183(1):25-8. PubMed ID: 3884380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic inactivation of Leu-enkephalin.
    MacKinnon KL; Zuzel KA; Billington D
    Regul Pept; 1996 Dec; 67(2):85-92. PubMed ID: 8958578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Naloxonazine effects on the interaction of enkephalin analogs with mu-1, mu and delta opioid binding sites in rat brain membranes.
    Cruciani RA; Lutz RA; Munson PJ; Rodbard D
    J Pharmacol Exp Ther; 1987 Jul; 242(1):15-20. PubMed ID: 3039108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and biological activity of monothionated analogs of leucine-enkephalin.
    Lajoie G; Lépine F; Lemaire S; Jolicoeur F; Aubé C; Turcotte A; Belleau B
    Int J Pept Protein Res; 1984 Oct; 24(4):316-27. PubMed ID: 6096283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significant differences in the disposition of cyclic prodrugs of opioid peptides in rats and guinea pigs following IV administration.
    Liederer BM; Phan KT; Ouyang H; Borchardt RT
    J Pharm Sci; 2005 Dec; 94(12):2676-87. PubMed ID: 16258984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma uptake and in vivo metabolism of [Leu]enkephalin following its intraperitoneal administration to rats.
    Schulteis G; Weinberger SB; Martinez JL
    Peptides; 1989; 10(5):913-9. PubMed ID: 2691996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood-brain barrier permeability to dipeptides and their constituent amino acids.
    Zlokovic BV; Begley DJ; Chain DG
    Brain Res; 1983 Jul; 271(1):65-71. PubMed ID: 6883121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of di- and trivalent metal ions on the complexing of D-ala2, D-leu5-enkephalin with opiate receptors of brain membrane preparations].
    Zaĭtsev SV; Porodenko NV; Varfolomeev SD
    Dokl Akad Nauk SSSR; 1984; 277(5):1260-3. PubMed ID: 6094131
    [No Abstract]   [Full Text] [Related]  

  • 29. The occurrence and receptor specificity of endogenous opioid peptides within the pancreas and liver of the rat. Comparison with brain.
    Khawaja XZ; Green IC; Thorpe JR; Titheradge MA
    Biochem J; 1990 Apr; 267(1):233-40. PubMed ID: 1970240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bis-penicillamine enkephalins possess highly improved specificity toward delta opioid receptors.
    Mosberg HI; Hurst R; Hruby VJ; Gee K; Yamamura HI; Galligan JJ; Burks TF
    Proc Natl Acad Sci U S A; 1983 Oct; 80(19):5871-4. PubMed ID: 6310598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disappearance of enkephalins in the isolated perfused rat lung.
    Manwaring D; Mullane K
    Life Sci; 1984 Oct; 35(17):1787-94. PubMed ID: 6384711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of enkephalin degrading enzymes by metal chelating reagents.
    Altstein M; Blumberg S; Vogel Z
    Adv Biochem Psychopharmacol; 1982; 33():261-70. PubMed ID: 6751033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for the presence of enkephalins in the heart.
    Lang RE; Hermann K; Dietz R; Gaida W; Ganten D; Kraft K; Unger T
    Life Sci; 1983 Jan; 32(4):399-406. PubMed ID: 6827901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential antagonism of opioid delta antinociception by [D-Ala2,Leu5,Cys6]enkephalin and naltrindole 5'-isothiocyanate: evidence for delta receptor subtypes.
    Jiang Q; Takemori AE; Sultana M; Portoghese PS; Bowen WD; Mosberg HI; Porreca F
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1069-75. PubMed ID: 1646319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tyr1-substituted and fluorescent Pya1-enkephalins bind strongly and selectively to mu and delta opiate receptors.
    Mihara H; Lee S; Shimohigashi Y; Aoyagi H; Kato T; Izumiya N; Costa T
    Biochem Biophys Res Commun; 1986 May; 136(3):1170-6. PubMed ID: 3013169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the binding characteristics of tritiated opiates and opioid peptides.
    Gillan MG; Kosterlitz HW; Paterson SJ
    Br J Pharmacol; 1980 Nov; 70(3):481-90. PubMed ID: 7437652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enkephalins and autoimmunity: differential effect of methionine-enkephalin on experimental allergic encephalomyelitis in Wistar and Lewis rats.
    Janković BD; Marić D
    J Neurosci Res; 1987; 18(1):88-94. PubMed ID: 3500326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Receptors for opioid peptides in the guinea-pig ileum.
    Takemori AE; Portoghese PS
    J Pharmacol Exp Ther; 1985 Nov; 235(2):389-92. PubMed ID: 2997432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Visualization of mu1 opiate receptors in rat brain by using a computerized autoradiographic subtraction technique.
    Goodman RR; Pasternak GW
    Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6667-71. PubMed ID: 2995978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Stability of opiate receptors of wet and lyophilized preparations of rat brain membranes].
    Zaĭtsev SV; Kurochkin IN; Sergeeva MG; Varfolomeev SD
    Biokhimiia; 1984 Jul; 49(7):1127-33. PubMed ID: 6089917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.